Logo

American Heart Association

  21
  0


Final ID:

From STICH to GLORIOUS: The evolution of coronary interventions

  • Chikwe, Joanna  ( Cedars-sinai , Los Aeles , California , United States )
  • Farkouh, Michael  ( Cedars-Sinai , Los Angeles , California , United States )
  • Author Disclosures:
    Joanna Chikwe: DO NOT have relevant financial relationships | Michael Farkouh: DO have relevant financial relationships ; Research Funding (PI or named investigator):Astrozenica:Active (exists now) ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

From Intervention to Prevention: Advances in Coronary and Valvular Heart Disease

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
Efficacy of a Glucagon-Like Peptide-1 Agonist in Patients undergoing Coronary Artery Bypass Grafting or Aortic Valve Replacement – a randomized clinical trial

Kjaergaard Jesper, Boesgaard Soeren, Kober Lars, Nilsson Jens Christian, Hassager Christian, Moeller Christian Holdflod, Wiberg Sebastian, Mikkelsen Astrid, Møller-sørensen Peter Hasse, Ravn Hanne Berg, Ravn Jesper, Olsen Peter Skov, Høfsten Dan

the CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine versus placebo and Spironolactone versus placebo in Patients with Myocardial Infarction. The results of the spironolactone factorial.

Jolly Sanjit

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available